Table 1 Baseline characteristics of the study cohort (n = 718)

Socio-demographic data

Age at surgery [y]

64.2 ± 6.7

Body size [cm]

177 ± 6

Body weight [kg]

85.8 ± 11.9

BMI [kg/m²]

27.4 ± 3.2

Karnofsky Index [%]

99 ± 4

Diabetes mellitus

101 (14.1%)

Urinary tract medical history

History of urinary tract infection

22 (3.1%)

Transurethral resection of bladder cancer

2 (0.3%)

Transurethral resection of the prostate

19 (2.7%)

Other interventions on the urinary tract

168 (23.5%)

Incontinence: no. of used pads (pre op.)

 0

687 (96.8%)

 Safety pad

15 (2.1%)

 1 pad and more

7 (1.0%)

ICIQ sum (pre op.)

0.21 ± 0.84

Surgical and oncological data

Diagnosis since [months]

2.1 [1.5, 3.0]

PSA pre op. [ng/ml]

7.81 [5.70, 11.9]

Prostate weight [g]

48 [38, 60]

Tumor stage

 pT1c

1 (0.1%)

 pT2

453 (63.1%)

 pT3

256 (35.7%)

 pT4

5 (0.7%)

Gleason sum

 ≤ 6

117 (16.3%)

 7

473 (66.0%)

 ≥ 8

127 (17.7%)

Surgical approach

 RARP

530 (83.8%)

 LRP

188 (26.2%)

Nerve sparing (realized)

 None

278 (38.7%)

 Unilateral

68 (9.5%)

 Bilateral

372 (51.8%)

Lymphadenectomy performed

546 (76.0%)

Duration of the op [min]

173 [145, 204]